State-owned Vietnam Pharmaceutical Corporation (Vinapharm), one of the leading Vietnamese pharma firms, plans to sell 35 per cent stake this year and another 30 per cent in 2020.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
